McKenna Mark C.

Chairman, President & CEO at Prometheus Biosciences, Inc.; President, Salix at BHC

Sold, on record
$15.2M
Dollars the filings state
Form 4 sales
5
Latest Mar 15, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale BHCUnusual
    Aug 19, 2019 2019

    Sold 10,773 shares at $21.83 ($235k)

    McKenna Mark C., President, Salix

    Sold 34.2% of holdings ($688k position)20,756 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Prometheus Biosciences, Inc.Unusual
    Jan 17, 2023 +1247 days

    Sold 25,000 shares at $118.99 ($3M)

    McKenna Mark C., Chairman, President & CEO

    Sold 31.2% of holdings ($9.5M position)55,144 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Prometheus Biosciences, Inc.Unusual
    Feb 17, 2023 +31 days

    Sold 63,680 shares at $120.82 ($7.7M)

    McKenna Mark C., Chairman, President & CEO

    Sold 53.6% of holdings ($14.4M position)55,144 shares leftFiling

  4. 4 Form 4 sale Prometheus Biosciences, Inc.Plan not stated
    Mar 3, 2023 +14 days

    Sold 11,320 shares at $125.14 ($1.4M)

    McKenna Mark C., Chairman, President & CEO

    Sold 17% of holdings ($8.3M position)55,144 shares leftFiling

  5. 5 Form 4 sale Prometheus Biosciences, Inc.Unusual
    Mar 15, 2023 +12 days

    Sold 25,000 shares at $116.14 ($2.9M)

    McKenna Mark C., Chairman, President & CEO

    Sold 31.2% of holdings ($9.3M position)55,144 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by McKenna Mark C.
Source
Mar 15, 2023Mar 17, 2023Prometheus Biosciences, Inc.Chairman, President & CEOForm 4 sale25,000$2.9M31.2%UnusualSEC
Mar 3, 2023Mar 3, 2023Prometheus Biosciences, Inc.Chairman, President & CEOForm 4 sale11,320$1.4M17.0%Plan not statedSEC
Feb 17, 2023Feb 17, 2023Prometheus Biosciences, Inc.Chairman, President & CEOForm 4 sale63,680$7.7M53.6%UnusualSEC
Jan 17, 2023Jan 19, 2023Prometheus Biosciences, Inc.Chairman, President & CEOForm 4 sale25,000$3M31.2%UnusualSEC
Aug 19, 2019Aug 21, 2019BHCPresident, SalixForm 4 sale10,773$235k34.2%UnusualSEC